AlphaFold predicted structure
GDF6 · Q6KF10

Mean pLDDT
70.1/ 100
Confident
455 residues
Confidence breakdown
- Very high(≥ 90)34%
- Confident(70–90)21%
- Low(50–70)13%
- Very low(< 50)32%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
growth differentiation factor 6
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedStructural eye disease
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDeafness and congenital structural abnormalities
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRetinal disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalAnophthalmia or microphthalmia
Currarino triad
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown+3 more panels — install the extension to see the full list inline on any page.
Klippel-Feil syndrome 1, autosomal dominant
isolated microphthalmia 4
Isolated anophthalmia - microphthalmia
Leber congenital amaurosis 17
multiple synostoses syndrome
microphthalmia, isolated, with coloboma
multiple synostoses syndrome 4
congenital anomaly of kidney and urinary tract
Leber congenital amaurosis
microphthalmia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Growth/differentiation factor 6
Growth factor that controls proliferation and cellular differentiation in the retina and bone formation. Plays a key role in regulating apoptosis during retinal development. Establishes dorsal-ventral positional information in the retina and controls the formation of the retinotectal map (PubMed:23307924). Required for normal formation of bones and joints in the limbs, skull, digits and axial skeleton. Plays a key role in establishing boundaries between skeletal elements during development. Regulation of GDF6 expression seems to be a mechanism for evolving species-specific changes in skeletal structures. Seems to positively regulate differentiation of chondrogenic tissue through the growth factor receptors subunits BMPR1A, BMPR1B, BMPR2 and ACVR2A, leading to the activation of SMAD1-SMAD5-SMAD8 complex. The regulation of chondrogenic differentiation is inhibited by NOG (PubMed:26643732). Also involved in the induction of adipogenesis from mesenchymal stem cells. This mechanism acts through the growth factor receptors subunits BMPR1A, BMPR2 and ACVR2A and the activation of SMAD1-SMAD5-SMAD8 complex and MAPK14/p38 (By similarity)
GDF6 · Q6KF10

Mean pLDDT
70.1/ 100
Confident
455 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0